Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for 18F-FDG Brain Imaging in Patients Examined for Suspected Dementia
暂无分享,去创建一个
Gaspar Delso | Timo Grimmer | Sibylle Ziegler | Stefan Förster | Sebastian Fürst | Stephan G Nekolla | Michael Souvatzoglou | Ambros J Beer | Alexander Drzezga | Markus Schwaiger | A. Drzezga | G. Delso | S. Fürst | S. Nekolla | M. Schwaiger | S. Ziegler | A. Beer | M. Souvatzoglou | M. Eiber | S. Förster | T. Grimmer | Matthias Eiber | Stefan Hitz | Cornelia Habekost | Cornelia Habekost | Stefan Hitz
[1] A. Drzezga,et al. First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses , 2012, The Journal of Nuclear Medicine.
[2] Koen Van Laere,et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[3] E. Reiman,et al. Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.
[4] et al.,et al. Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET , 2002, NeuroImage.
[5] S Minoshima,et al. Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] Y. Yuan,et al. Fluorodeoxyglucose–Positron-Emission Tomography, Single-Photon Emission Tomography, and Structural MR Imaging for Prediction of Rapid Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis , 2008, American Journal of Neuroradiology.
[7] Jeffrey L. Cummings,et al. Practice parameter: Diagnosis of dementia (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .
[8] Ian Law,et al. Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone , 2014, NeuroImage.
[9] B. Miller,et al. CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .
[10] Victor L. Villemagne,et al. Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease , 2005, Journal of Clinical Neuroscience.
[11] Nassir Navab,et al. Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data , 2009, Journal of Nuclear Medicine.
[12] Thomas Beyer,et al. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. , 2003, Seminars in nuclear medicine.
[13] Paul Kinahan,et al. Attenuation correction for a combined 3D PET/CT scanner. , 1998, Medical physics.
[14] Alexander Hammers,et al. Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18 , 2008, Psychiatry Research: Neuroimaging.
[15] Sanjiv S Gambhir,et al. Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] C. Rowe,et al. Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias , 2011, The Journal of Nuclear Medicine.
[17] A. Drzezga. Diagnosis of Alzheimer’s Disease with [18F]PET in Mild and Asymptomatic Stages , 2009, Behavioural neurology.
[18] Ciprian Catana,et al. Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] S. Vandenberghe,et al. MRI-Based Attenuation Correction for PET/MRI Using Ultrashort Echo Time Sequences , 2010, Journal of Nuclear Medicine.
[20] J. S. Lee,et al. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] M. Mintun,et al. Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects , 2012, The Journal of Nuclear Medicine.
[22] Adam Johansson,et al. CT substitute derived from MRI sequences with ultrashort echo time. , 2011, Medical physics.
[23] Karl J. Friston,et al. Spatial registration and normalization of images , 1995 .
[24] M. Schwaiger,et al. Standardised uptake values from PET/CT images: comparison with conventional attenuation-corrected PET , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[25] Bernhard Schölkopf,et al. MRI-Based Attenuation Correction for PET/MRI: A Novel Approach Combining Pattern Recognition and Atlas Registration , 2008, Journal of Nuclear Medicine.
[26] R. Koeppe,et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] Ciprian Catana,et al. Toward Implementing an MRI-Based PET Attenuation-Correction Method for Neurologic Studies on the MR-PET Brain Prototype , 2010, The Journal of Nuclear Medicine.
[28] M. Hüll,et al. Disease-Modifying Therapies in Alzheimer’s Disease , 2012, Drugs.
[29] M. Hüll,et al. Disease-modifying therapies in Alzheimer's disease: how far have we come? , 2006, Drugs.
[30] Ernst J. Rummeny,et al. Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[31] Bradford C. Dickerson,et al. Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay , 2012, Biological Psychiatry.
[32] Matthias Hofmann,et al. Hybrid PET/MRI of Intracranial Masses: Initial Experiences and Comparison to PET/CT , 2010, The Journal of Nuclear Medicine.
[33] G. Delso,et al. PET–MR imaging using a tri-modality PET/CT–MR system with a dedicated shuttle in clinical routine , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.
[34] Ciprian Catana,et al. PET/MRI for Neurologic Applications , 2012, The Journal of Nuclear Medicine.
[35] G. Delso,et al. Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner , 2011, The Journal of Nuclear Medicine.
[36] Yvette I. Sheline,et al. Potential antecedent marker of Alzheimer disease , 2006 .
[37] Arno Villringer,et al. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies , 2010, NeuroImage.